Question 1

Is Betamethasonvalerat (Ph.Eur.) currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Betamethasonvalerat (Ph.Eur.) has 3 active shortage notices across 1 country (Germany). Status is refreshed daily from official regulatory sources.

Question 2

Why is Betamethasonvalerat (Ph.Eur.) in shortage?

Accepted Answer

Regulators attribute the current Betamethasonvalerat (Ph.Eur.) shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Betamethasonvalerat (Ph.Eur.) shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 26 Apr 2026 to 21 Jun 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Betamethasonvalerat (Ph.Eur.) shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.

Betamethasonvalerat (Ph.Eur.) shortage status

Where Betamethasonvalerat (Ph.Eur.) is in shortage

Why Betamethasonvalerat (Ph.Eur.) is in shortage

Frequently asked questions

Get alerted when Betamethasonvalerat (Ph.Eur.) status changes